Skip to content

Financial Reports

Our financial reports are only available in Swedish.


Subscribe to AcuCort's newsletter

* indicates required

We make good drugs better

AcuCort develops innovative treatments based on existing and well-documented substances in treatment areas where there is a high unmet medical need and commercial interest in new drugs that add benefits such as simplicity of administration.

Latest videos from AcuCort

Presentation av kvartalsrapport Q1 2024

AcuCort AB

April 26, 2024 15:02

Jonas Jönmark presenterar de senaste händelserna på Invest Live

AcuCort AB

March 13, 2024 11:50

Acucort – Stora Aktiedagen 5 mars 2024

AcuCort AB

March 6, 2024 14:00

AcuCort presenterar på Invest Live

AcuCort AB

February 6, 2024 20:54

AcuCort – Invest Live

AcuCort AB

October 26, 2023 13:53

AcuCort at BioStock Life Science Spring Summit 2023

AcuCort AB

June 1, 2023 08:45